← Back to patent-cliff list
CAS 463-78-5
methanetriol
Codes: DECI-004
Application context (from source-drug indications)
Allergic reactionDecitabineCycloplegiaDecitabineHypotensionDecitabineAcute myeloid leukaemiaDecitabineMyelodysplastic syndromeDecitabineDiffuse large B-cell lymphomaDecitabine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Decitabine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
((2R,3S)-3-acetoxy-5-isocyanatotetrahydrofuran-2-yl)methyl acetate→methyl carbamimidothioate→((2R,3S)-3-acetoxy-5-(3-((E)-amino(methylthio)methylene)ureido)tetrahydrofuran-2-yl)methyl acetate→methanetriol→((2R,3S,5R)-3-acetoxy-5-(4-(methylthio)-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.